Hippocratic AI, a California-based company specializing in generative AI for healthcare, has raised $141 million in a Series B funding round led by Kleiner Perkins, bringing its valuation to $1.64 billion. The funding will accelerate the development and deployment of its GenAI-driven “super staffing” solutions, aimed at addressing healthcare staffing shortages and improving operational efficiency. The company’s AI agents handle nondiagnostic, patient-facing clinical tasks on behalf of clinicians, with hundreds of thousands of calls already completed for health organizations such as OhioHealth, Cincinnati Children’s, and WellSpan Health. Kleiner Perkins partner Mamoon Hamid highlighted the vast market potential of generative AI in healthcare, estimating it to be 10 times larger than the traditional healthcare software market.
In addition to the funding, Hippocratic AI launched its Healthcare AI Agent App Store, enabling clinicians to design and shape AI agents for specific patient care and operational challenges. Clinicians can create agents in under 30 minutes, with rigorous safety testing to ensure reliability. The platform allows creators to earn revenue, receiving 5% of the base fee and 70% of any premium rates set. This innovation, combined with the company’s previous $53 million funding round and recent partnerships with healthcare organizations, underscores its rapid growth in the “direct work engagement” category, where it is recognized as a leader in applying generative AI to workforce solutions.
Read the full article here